OR52W1: A Potential Drug Target and Biomarker (G120787)
OR52W1: A Potential Drug Target and Biomarker
OR52W1 is a small non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is located in the OR52 gene, which encodes the protein Ovulonectin (OVN), a protein that is expressed in the ovarian tissue and has been shown to have various functions, including regulating cell growth, apoptosis, and angiogenesis.
The discovery of OR52W1 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases, including cancer, ovarian disease, and neurodegenerative disorders. OR52W1 has been shown to play a role in the regulation of cell proliferation and has been associated with the development of various types of cancer, including breast, ovarian, and prostate cancer.
In addition to its potential as a drug target, OR52W1 has also been identified as a potential biomarker for various diseases. The expression of OR52W1 has been shown to be downregulated in various types of cancer, including breast, ovarian, and prostate cancer, and has been associated with poor prognosis. This suggests that OR52W1 may be a useful biomarker for the diagnosis and prognosis of these diseases.
The identification of OR52W1 as a potential drug target and biomarker also has implications for the development of new diagnostic tests for these diseases. By targeting OR52W1 with drugs, researchers may be able to inhibit its activity and reduce the growth and spread of cancer cells. This may lead to earlier detection and more effective treatment of these diseases.
In conclusion, OR52W1 is a promising drug target and biomarker that has the potential to revolutionize the treatment of various diseases. Further research is needed to fully understand its role in the regulation of cell growth and its potential as a drug and biomarker.
Protein Name: Olfactory Receptor Family 52 Subfamily W Member 1
Functions: Odorant receptor
The "OR52W1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR52W1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P
